Uncategorized

Stuzo acquired by Dachis Group

Stuzo, the Fairmount-based Facebook application development shop has been acquired by the Dachis Group according to Techcrunch and a message from Stuzo founder Gunther Pfau to Technically Philly. Pfau declined to disclose any details but said that he will continue to helm Stuzo and the company will remain in the city as an operating unit of Dachis. […]

Stuzo, the Fairmount-based Facebook application development shop has been acquired by the Dachis Group according to Techcrunch and a message from Stuzo founder Gunther Pfau to Technically Philly.
Pfau declined to disclose any details but said that he will continue to helm Stuzo and the company will remain in the city as an operating unit of Dachis.
“We’re looking to bring on board more technical, project management, and account talent,” said Pfau.
Stuzo started in 2005 as a platform for college students to trade textbooks and other goods at Temple University before pivoting to become one of the first developers on the Facebook Application platform.
“It didn’t completely gain traction,” admitted Pfau in a video interview last year.”We really made a decision overnight … to change gears.”
The company began building apps like MyHeritage before focusing more on promotions for other brands like Coca-Cola and Proctor and Gamble, quickly becoming one of the largest Facebook development shops in the country.
The Dachis Group, based in Austin, is a “social business consultancy” with many of same clients as Stuzo.

Companies: Stuzo
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Donate to the Journalism Fund

Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.

Trending

You've heard the term 'valuation' on 'Shark Tank.' What does it actually mean?

Ecommerce founder reveals how her startup raised millions and won international acclaim

Does the Spark Therapeutics writedown undermine Philly’s biotech swagger?

This pharma startup backed by Y Combinator aims to treat multiple diseases, for good

Technically Media